Generic Name: Eribulin (er i BUE lin)

Trade Name(s): Halaven ®

Eribulin is the generic name for the trade name drug Halaven. In some cases, health care professionals may use the trade name Halaven when referring to the generic drug name eribulin.

Drug Type

Halaven is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. This medication is classified as a ­­­­­­­­­non-taxane microtubule inhibitor. (For more detail, see “How Halaven Works” below)

What Halaven Is Used For:

Halaven is used for the treatment of patients with metastatic breast cancer.

Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.

How Halaven Is Given:
  • Halaven is given through a vein as an intravenous push or as intravenous infusion over 2 to 5 minutes.

The amount of Halaven that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition you have. Your doctor will determine your exact dosage and schedule.

Side effects of Halaven:

Important things to remember about the side effects of Halaven:
  • Most people will not experience all of the Halaven side effects listed.
  • Halaven side effects are often predictable in terms of their onset, duration, and severity.
  • Halaven side effects will improve after therapy is complete.
  • Halaven side effects may be quite manageable.
  • There are many options to minimize or prevent the side effects of Halaven.

The following side effects are common (occurring in greater than 30%) for patients taking Halaven:

  • Low blood counts. Your white and red blood cells may temporarily decrease. This can put you at increased risk for infection and/or anemia.
  • Nadir: (approximately 13 days; recovery approximately 8 days)
  • Fatigue/weakness
  • Hair loss
  • Nausea
  • Peripheral neuropathy (numbness and tingling of the hands and feet)

These are less common (occurring in 10-29%) side effects for patients receiving Halaven:

  • Constipation
  • Arthralgia/myalgia (pain in the joints/muscles)
  • Fever
  • Weight loss
  • Loss of appetite
  • Headache
  • Diarrhea
  • Vomiting
  • Mouth sores
  • Increase in blood test measuring liver function
  • Back pain
  • Shortness of breath
  • Cough
  • Bone pain